Role of Immune Escape Mechanisms in Hodgkin's Lymphoma Development and Progression: A Whole New World with Therapeutic Implications

Figure 5

Therapeutic strategies to overcome immune escape in HL. AcMo: monoclonal antibodies. H/RS cells: Hodgkin’s/Reed-Sternberg cells. CTL: cytotoxic T lymphocytes. HMGB1: high-mobility group protein B1. TLR4: Toll-like receptor 4.